Inquiry and Innovation
Research is a core component of the University of Wisconsin Infectious Disease fellowship. Since 1980, 87 percent of our fellows entered academic careers upon completion of their fellowship and five are considered international authorities in a major area of infectious disease or microbiologic research.
With support from investigators in our division, department and campus, you’ll participate in innovative research and learn to develop your own projects.
Learn more about our department’s research environment.
Personalized Research Experience
Depending on your interests, you can develop independent research projects and/or participate in existing projects of our division members or other investigators on campus.
Fellows have worked in research laboratories in the Departments of Biochemistry, Microbiology and Immunology, Pharmacology, Bacteriology, Public Health, and in the State Division of Health.
Our program structure allows you to spend roughly half of your time participating in research.
Opportunities for Collaboration
Whether you are interested in basic, translational, clinical or health services research, there’s a collaborator for you here.
Our faculty are just a fraction of the collaborative microbial sciences research that takes place across campus. The UW-Madison microbial sciences research program was ranked in the top two nationally by U.S. News and World Reports in 2019.
Here are some opportunities that might interest you:
- Division of Infectious Disease research
- Department of Medical Microbiology and Immunology
- McArdle Laboratory for Cancer Research
- UW School of Pharmacy
- Global Health Institute
- Population Health Sciences
Presentations, Publications and Awards
Over the years, our fellows have co-authored more than 50 research publications and have been invited to submit monographs, chapters and/or abstracts at peer-reviewed national and international scientific meetings.
All fellows have the opportunity to attend and present at these conferences:
- American Society for Microbiology (ASM)
- Infectious Disease Society of America (IDSA)
- Society for Healthcare Epidemiology of America (SHEA)
- Department of Medicine Research Day
- UW Health Quality Improvement Symposium
You're required to participate in a minimum of one local or national professional conference presentation during training. We make it a priority to support you in this effort. For senior fellows, we provide support to attend ID Week or SHEA regardless of presentation. For any fellow scholarly work accepted for presentation, we will consider financial support to attend a meeting on case-by-case basis.
By graduation, most fellows author high impact publications. Some have won prestigious national research awards, including the Pearl M. Stetler Award, SHEA Outstanding Trainee Awards, NIH Mentored Clinical Scientist Development Award, Fellow of the American College of Physicians, and NIH Loan Repayment Awards.
Fellows who display an aptitude for research may be offered an additional training year dedicated to full-time investigation.
- Recent Learner Publications
- Berman L, Kavalier M (fellow), Gelana B, Tesfaw G, Siraj D, Shirley D, et al. (2021) Utilizing the SEIPS model to guide hand hygiene interventions at a tertiary hospital in Ethiopia. PLoS ONE 16(10): e0258662.
- Kessler MA (fellow), Joachim EL, Narayanan D, Medani S, Urban AW, Parajuli S. On the tip of my tongue: A 76-year-old female kidney transplant patient with tongue ulcer. Transpl Infect Dis. 2020 Jun 25:e13389. doi: 10.1111/tid.13389.
- Jasper AS, Musuuza JS, Tischendorf JS (fellow), Stevens VW, Gamage SD, Osman F, Safdar N. Are Fluoroquinolones or Macrolides Better for Treating Legionella Pneumonia? A Systematic Review and Meta-analysis. Clin Infect Dis. 2020 Apr 16:ciaa441. doi: 10.1093/cid/ciaa441. Online ahead of print.PMID: 32296816
- Pop-Vicas A, Stern R (resident), Osman F, Safdar N. Variability in infection surveillance methods and impact on surgical site infection rates. Am J Infect Control. 2020 Jul 2:S0196-6553(20)30635-0. doi: 10.1016/j.ajic.2020.06.211. Online ahead of print.PMID: 32622837
- Horton MV (graduate student), Johnson CJ, Kernien JF, Patel TD, Lam BC, Cheong JZA, Meudt JJ, Shanmuganayagam D, Kalan LR, Nett JE. Candida auris Forms High-Burden Biofilms in Skin Niche Conditions and on Porcine Skin. mSphere. 2020 Jan 22;5(1):e00910-19. doi: 10.1128/mSphere.00910-19.PMID: 31969479
- Zelenski AB, Tischendorf JS (fellow), Kessler M (fellow), Saunders S, MacDonald MM, Vogelman B, Zakowski L.J Beyond "Read More": An Intervention to Improve Faculty Written Feedback to Learners. Grad Med Educ. 2019 Aug;11(4):468-471. doi: 10.4300/JGME-D-19-00058.1.PMID: 31440343
- Tischendorf JS (fellow), Knobloch MJ, Musuuza JS, Safdar N. Using a Systems Engineering Framework to Evaluate Proton Pump Inhibitor Prescribing in Critically Ill Patients. J Healthc Qual. 2020 Jul/Aug;42(4):e39-e49. doi: 10.1097/
- McCreary EK (resident), Bayless M, Van AP, Lepak AJ, Wiebe DA, Schulz LT, Andes DR. Impact of Triazole Therapeutic Drug Monitoring Availability and Timing. Antimicrob Agents Chemother. 2019 Sep 23;63(10):e01245-19. doi: 10.1128/AAC.01245-19. Print 2019 Oct.PMID: 31332058
- Hovel EM, Pease RC (fellow), Scarano AJ, Chen DJ, Saddler CM. Bordetella pertussis in a four-time kidney transplant recipient: A call for immunization programs at transplant centers. Transpl Infect Dis. 2019 Aug;21(4):e13120. doi: 10.1111/tid.13120. Epub 2019 Jun 14.PMID: 31124247
- Lepak AJ, Zhao M (graduate student), Marchillo K, VanHecker J, Andes DR. In Vivo Pharmacodynamic Evaluation of Omadacycline against Staphylococcus aureus in the Neutropenic Mouse Pneumonia Model. Antimicrob Agents Chemother. 2020 Jan 27;64(2):e02058-19. doi: 10.1128/AAC.02058-19. Print 2020 Jan 27.PMID: 31712210
- Lepak AJ, Zhao M (graduate student), Andes DR. WCK 5222 (Cefepime/Zidebactam) Pharmacodynamic Target Analysis against Metallo-β-lactamase producing Enterobacteriaceae in the Neutropenic Mouse Pneumonia Model. Antimicrob Agents Chemother. 2019 Oct 7;63(12):e01648-19. doi: 10.1128/AAC.01648-19. Online ahead of print.PMID: 31591114
- Lepak AJ, Zhao M (graduate student), Andes DR. Determination of Pharmacodynamic Target Exposures for Rezafungin against Candida tropicalis and Candida dubliniensis in the Neutropenic Mouse Disseminated Candidiasis Model. Antimicrob Agents Chemother. 2019 Oct 22;63(11):e01556-19. doi: 10.1128/AAC.01556-19. Print 2019 Nov.PMID: 31481440
- Dominguez EG (graduate student), Zarnowski R, Choy HL, Zhao M, Sanchez H, Nett JE, Andes DR. Conserved Role for Biofilm Matrix Polysaccharides in Candida auris Drug Resistance. mSphere. 2019 Jan 2;4(1):e00680-18. doi: 10.1128/mSphereDirect.00680-18.PMID: 30602527
- Zhao M (graduate student), Lepak AJ, Marchillo K, Andes DR. In Vivo Pharmacodynamic Target Determination for Delafloxacin against Klebsiella pneumoniae and Pseudomonas aeruginosa in the Neutropenic Murine Pneumonia Model. Antimicrob Agents Chemother. 2019 Sep 23;63(10):e01131-19. doi: 10.1128/AAC.01131-19. Print 2019 Oct.PMID: 31332063
- Lepak AJ, Zhao M (graduate student), Marchillo K, VanHecker J, Andes DR. In Vivo Pharmacodynamics of Omadacycline against Staphylococcus aureus in the Neutropenic Murine Thigh Infection Model. Antimicrob Agents Chemother. 2019 Jun 24;63(7):e00624-19. doi: 10.1128/AAC.00624-19. Print 2019 Jul.PMID: 31036691
- Zhao M (graduate student), Lepak AJ, Marchillo K, Vanhecker J, Sanchez H, Ambrose PG, Andes DR. APX001 Pharmacokinetic/Pharmacodynamic Target Determination against Aspergillus fumigatus in an In Vivo Model of Invasive Pulmonary Aspergillosis. Antimicrob Agents Chemother. 2019 Mar 27;63(4):e02372-18. doi: 10.1128/AAC.02372-18. Print 2019 Apr.PMID: 30670426
- McBride JA (fellow), Gauthier GM, Klein BS. Turning on virulence: Mechanisms that underpin the morphologic transition and pathogenicity of Blastomyces. Virulence. 2019 Dec;10(1):801-809. doi: 10.1080/21505594.2018.1449506. Epub 2018 Aug 1.PMID: 29532714
- Matchett C, Djamali A, Mandelbrot D, Saddler C (fellow), Parajuli S. Nocardia infection in kidney transplant recipients: A single-center experience. C, Djamali A, Mandelbrot D, Saddler C, Parajuli S.Transpl Infect Dis. 2019 Dec;21(6):e13192. doi: 10.1111/tid.13192. Epub 2019 Nov 1.PMID: 31596020
- Jorgenson MR, Descourouez JL, Yang DY, Leverson GE, Saddler CM (fellow), Smith JA, Safdar N, Mandlebrot DA, Redfield RR. Epidemiology, Risk Factors, and Outcomes After Early Posttransplant Clostridiodes difficile Infection in Renal Transplant Recipients. Ann Pharmacother. 2019 Oct;53(10):1020-1025. doi: 10.1177/1060028019845003. Epub 2019 Apr 21.PMID: 31007034
- Jorgenson MR, Descourouez JL, Cardinale B, Lyu B, Astor BC, Garg N, Saddler CM (fellow), Smith JA, Mandelbrot DA. Risk of opportunistic infection in kidney transplant recipients with cytomegalovirus infection and associated outcomes. Transpl Infect Dis. 2019 Jun;21(3):e13080. doi: 10.1111/tid.13080. Epub 2019 Apr 16.PMID: 30891915
- Rolak S, Di Bartolomeo S, Jorgenson MR, Saddler CM (fellow), Singh T, Astor BC, Parajuli S. Outcomes of Norovirus diarrheal infections and Clostridioides difficile infections in kidney transplant recipients: A single-center retrospective study. Transpl Infect Dis. 2019 Apr;21(2):e13053. doi: 10.1111/tid.13053. Epub 2019 Feb 11.PMID: 30689283
- Lepak AJ, Zhao M (graduate student), Liu Q, Wang P, Wang Y, Bader JC, Ambrose PG, Andes DR. Pharmacokinetic/Pharmacodynamic Evaluation of a Novel Aminomethylcycline Antibiotic, KBP-7072, in the Neutropenic Murine Pneumonia Model against Staphylococcus aureus and Streptococcus pneumoniae. Antimicrob Agents Chemother. 2019 Feb 26;63(3):e02404-18. doi: 10.1128/AAC.02404-18. Print 2019 Mar.PMID: 30559140
- Kates AE, Tischendorf JS (fellow), Schweizer M, Herwaldt L, Samore M, Dukes KC, Gerding DN, Diekema DJ, Safdar N. Research Agenda for Microbiome Based Research for Multidrug-resistant Organism Prevention in the Veterans Health Administration System. Infect Control Hosp Epidemiol. 2018 Feb;39(2):202-209. doi: 10.1017/ice.2017.311.PMID: 29417924
- Lepak AJ, Zhao M (graduate student), Andes DR. Pharmacodynamic Evaluation of Rezafungin (CD101) against Candida auris in the Neutropenic Mouse Invasive Candidiasis Model. Antimicrob Agents Chemother. 2018 Oct 24;62(11):e01572-18. doi: 10.1128/AAC.01572-18. Print 2018 Nov.PMID: 30181375
- Zarnowski R, Sanchez H, Covelli AS (graduate student), Dominguez E, Jaromin A, Bernhardt J, Mitchell KF, Heiss C, Azadi P, Mitchell A, Andes DR. Candida albicans biofilm-induced vesicles confer drug resistance through matrix biogenesis. PLoS Biol. 2018 Oct 8;16(10):e2006872. doi: 10.1371/journal.pbio.2006872. eCollection 2018 Oct.PMID: 30296253
- Zhao M (graduate student), Lepak AJ, Marchillo K, VanHecker J, Andes DR. In Vivo Pharmacodynamic Characterization of a Novel Odilorhabdin Antibiotic, NOSO-502, against Escherichia coli and Klebsiella pneumoniae in a Murine Thigh Infection Model. Antimicrob Agents Chemother. 2018 Aug 27;62(9):e01067-18. doi: 10.1128/AAC.01067-18. Print 2018 Sep.PMID: 29987156
- Hoyer AR (undergraduate), Johnson CJ, Hoyer MR, Kernien JF (graduate student), Nett JE. Echinocandin Treatment of Candida albicans Biofilms Enhances Neutrophil Extracellular Trap Formation. Antimicrob Agents Chemother. 2018 Aug 27;62(9):e00797-18. doi: 10.1128/AAC.00797-18. Print 2018 Sep.PMID: 29987146
- Dominguez E (graduate student), Zarnowski R, Sanchez H, Covelli AS, Westler WM, Azadi P, Nett J, Mitchell AP, Andes DR. Conservation and Divergence in the Candida Species Biofilm Matrix Mannan-Glucan Complex Structure, Function, and Genetic Control. mBio. 2018 Apr 3;9(2):e00451-18. doi: 10.1128/mBio.00451-18.PMID: 29615504
- Kernien JF (graduate student), Snarr BD, Sheppard DC, Nett JE. The Interface between Fungal Biofilms and Innate Immunity. Front Immunol. 2018 Jan 10;8:1968. doi: 10.3389/fimmu.2017.01968. eCollection 2017.PMID: 29375581
- Johnson CJ, Davis JM (fellow), Huttenlocher A, Kernien JF, Nett JE. Emerging Fungal Pathogen Candida auris Evades Neutrophil Attack. mBio. 2018 Aug 21;9(4):e01403-18. doi: 10.1128/mBio.01403-18.PMID: 30131360
- Zhao M (graduate student), Lepak AJ, VanScoy B, Bader JC, Marchillo K, Vanhecker J, Ambrose PG, Andes DR. In Vivo Pharmacokinetics and Pharmacodynamics of APX001 against Candida spp. in a Neutropenic Disseminated Candidiasis Mouse Model. Antimicrob Agents Chemother. 2018 Mar 27;62(4):e02542-17. doi: 10.1128/AAC.02542-17. Print 2018 Apr.PMID: 29378706
- McBride JA (fellow), Lepak AJ, Dhaliwal G, Saint S, Safdar N. The Wrong Frame of Mind. N Engl J Med. 2018 May 3;378(18):1716-1721. doi: 10.1056/NEJMcps1710814.PMID: 29719187
- Lepak AJ, Zhao M (graduate student), VanScoy B, Ambrose PG, Andes DR. Pharmacodynamics of a Long-Acting Echinocandin, CD101, in a Neutropenic Invasive-Candidiasis Murine Model Using an Extended-Interval Dosing Design. Antimicrob Agents Chemother. 2018 Jan 25;62(2):e02154-17. doi: 10.1128/AAC.02154-17. Print 2018 Feb.PMID: 29203480
- Thompson KM, Sterkel AK, McBride JA (fellow), Corliss RF. The Shock of Strep: Rapid Deaths Due to Group a Streptococcus. Acad Forensic Pathol. 2018 Mar;8(1):136-149. doi: 10.23907/2018.010. Epub 2018 Mar 7.PMID: 31240031
- Garg N, Jorgenson M, Descourouez J, Saddler CM (fellow), Parajuli S, Astor BC, Djamali A, Mandelbrot D. Pneumocystis jiroveci pneumonia in kidney and simultaneous pancreas kidney transplant recipients in the present era of routine post-transplant prophylaxis: risk factors and outcomes. BMC Nephrol. 2018 Nov 21;19(1):332. doi: 10.1186/s12882-018-1142-8.PMID: 30463516
- Misch EA, Saddler C (fellow), Davis JM. Skin and Soft Tissue Infections Due to Nontuberculous Mycobacteria. Curr Infect Dis Rep. 2018 Mar 19;20(4):6. doi: 10.1007/s11908-018-0611-3.PMID: 29556857
- Splinter LE, Kerstenetzky L, Jorgenson MR, Descourouez JL, Leverson GE, Saddler CM (fellow), Smith JA, Safdar N, Redfield RR. Vancomycin Prophylaxis for Prevention of Clostridium difficile Infection Recurrence in Renal Transplant Patients. Ann Pharmacother. 2018 Feb;52(2):113-119. doi: 10.1177/1060028017727756. Epub 2017 Aug 26.PMID: 28844154
- Barker AK, Zellmer C, Tischendorf J (fellow), Duster M, Valentine S, Wright MO, Safdar N. On the hands of patients with Clostridium difficile: A study of spore prevalence and the effect of hand hygiene on C difficile removal. Am J Infect Control. 2017 Oct 1;45(10):1154-1156. doi: 10.1016/j.ajic.2017.03.005.PMID: 28964347
- Lepak AJ, Zhao M (graduate student), Berkow EL, Lockhart SR, Andes DR. Pharmacodynamic Optimization for Treatment of Invasive Candida auris Infection. Antimicrob Agents Chemother. 2017 Jul 25;61(8):e00791-17. doi: 10.1128/AAC.00791-17. Print 2017 Aug.PMID: 28584152
- McBride JA (fellow), Sterkel AK, Rehrauer WM, Smith JA. First described case of prosthetic joint infection with Clostridium disporicum. Anaerobe. 2017 Dec;48:56-58. doi: 10.1016/j.anaerobe.2017.06.022. Epub 2017 Jul 1.PMID: 28673848
- Brennan MB, Allen GO, Ferguson PD, McBride JA (fellow), Crnich CJ, Smith MA The Association Between Geographic Density of Infectious Disease Physicians and Limb Preservation in Patients With Diabetic Foot Ulcers. Open Forum Infect Dis. 2017 Feb 20;4(1):ofx015. doi: 10.1093/ofid/ofx015. eCollection 2017 Winter.PMID: 28480286
- Shirley D, Scholtz H (fellow), Osterby K, Musuuza J, Fox B, Safdar N. Optimizing Inpatient Urine Culture Ordering Practices Using the Electronic Medical Record: A Pilot Study. Infect Control Hosp Epidemiol. 2017;38(4):486-488. doi:10.1017/ice.2016.301
- Johnson CJ, Kernien JF (graduate student), Hoyer AR, Nett JE. Mechanisms involved in the triggering of neutrophil extracellular traps (NETs) by Candida glabrata during planktonic and biofilm growth. Sci Rep. 2017 Oct 12;7(1):13065. doi: 10.1038/s41598-017-13588-6.PMID: 29026191
- McBride JA (fellow), Striker R. Imbalance in the game of T cells: What can the CD4/CD8 T-cell ratio tell us about HIV and health? PLoS Pathog. 2017 Nov 2;13(11):e1006624. doi: 10.1371/journal.ppat.1006624. eCollection 2017 Nov.PMID: 29095912
- Brennan MB, Allen GO, Ferguson PD, McBride JA (fellow), Crnich CJ, Smith MA. The Association Between Geographic Density of Infectious Disease Physicians and Limb Preservation in Patients With Diabetic Foot Ulcers. Open Forum Infect Dis. 2017 Feb 20;4(1):ofx015. doi: 10.1093/ofid/ofx015. eCollection 2017 Winter.PMID: 28480286
- Zhao M (graduate student), Lepak AJ, Marchillo K, VanHecker J, Andes DR. In Vivo Pharmacodynamic Target Assessment of Eravacycline against Escherichia coli in a Murine Thigh Infection Model. Antimicrob Agents Chemother. 2017 Jun 27;61(7):e00250-17. doi: 10.1128/AAC.00250-17. Print 2017 Jul.PMID: 28416552
- Kernien JF (graduate student), Johnson CJ, Nett JE. Conserved Inhibition of Neutrophil Extracellular Trap Release by Clinical Candida albicans Biofilms. Version 2. J Fungi (Basel). 2017 Sep;3(3):49. doi: 10.3390/jof3030049. Epub 2017 Sep 6.PMID: 28944225
- McBride JA (fellow), Gauthier GM, Klein BS. Clinical Manifestations and Treatment of Blastomycosis. Clin Chest Med. 2017 Sep;38(3):435-449. doi: 10.1016/j.ccm.2017.04.006. Epub 2017 Jun 12.PMID: 28797487
- Lepak AJ, Zhao M (graduate student), Andes DR. Comparative Pharmacodynamics of Telavancin and Vancomycin in the Neutropenic Murine Thigh and Lung Infection Models against Staphylococcus aureus. Antimicrob Agents Chemother. 2017 Jun 27;61(7):e00281-17. doi: 10.1128/AAC.00281-17. Print 2017 Jul.PMID: 28416551
- McElligott M, Welham G, Pop-Vicas A, Taylor L (fellow), Crnich CJ. Antibiotic Stewardship in Nursing Facilities. Infect Dis Clin North Am. 2017 Dec;31(4):619-638. doi: 10.1016/j.idc.2017.07.008.PMID: 29079152
- Lepak AJ, Zhao M (graduate student), VanScoy B, Taylor DS, Ellis-Grosse E, Ambrose PG, Andes DR. In Vivo Pharmacokinetics and Pharmacodynamics of ZTI-01 (Fosfomycin for Injection) in the Neutropenic Murine Thigh Infection Model against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2017 May 24;61(6):e00476-17. doi: 10.1128/AAC.00476-17. Print 2017 Jun.PMID: 28396549
- Lepak AJ, Zhao M (graduate student), Marchillo K, VanHecker J, Andes DR. In Vivo Pharmacodynamic Evaluation of Omadacycline (PTK 0796) against Streptococcus pneumoniae in the Murine Pneumonia Model. Antimicrob Agents Chemother. 2017 Apr 24;61(5):e02368-16. doi: 10.1128/AAC.02368-16. Print 2017 May.PMID: 28193651
- Arriola V, Tischendorf J (fellow), Musuuza J, Barker A, Rozelle JW, Safdar N. Assessing the Risk of Hospital-Acquired Clostridium Difficile Infection With Proton Pump Inhibitor Use: A Meta-Analysis. Infect Control Hosp Epidemiol. 2016 Dec;37(12):1408-1417. doi: 10.1017/ice.2016.194. Epub 2016 Sep 28.PMID: 27677811
- Tischendorf J (fellow), de Avila RA, Safdar N. Risk of infection following colonization with carbapenem-resistant Enterobactericeae: A systematic review. Am J Infect Control. 2016 May 1;44(5):539-43. doi: 10.1016/j.ajic.2015.12.005. Epub 2016 Feb 15.PMID: 26899297
- Zhao M (graduate student), Lepak AJ, Andes DR. Animal models in the pharmacokinetic/pharmacodynamic evaluation of antimicrobial agents. Bioorg Med Chem. 2016 Dec 15;24(24):6390-6400. doi: 10.1016/j.bmc.2016.11.008. Epub 2016 Nov 9.PMID: 27887963
- Johnson CJ, Cabezas-Olcoz J, Kernien JF (graduate student), Wang SX, Beebe DJ, Huttenlocher A, Ansari H, Nett JE. The Extracellular Matrix of Candida albicans Biofilms Impairs Formation of Neutrophil Extracellular Traps. PLoS Pathog. 2016 Sep 13;12(9):e1005884. doi: 10.1371/journal.ppat.1005884. eCollection 2016 Sep.PMID: 27622514
- Chopra T, Awali RA, Biedron C, Vallin E, Bheemreddy S, Saddler CM (fellow), Mullins K, Echaiz JF, Bernabela L, Severson R, Marchaim D, Lephart P, Johnson L, Thyagarajan R, Kaye KS, Alangaden G. Predictors of Clostridium difficile infection-related mortality among older adults. Am J Infect Control. 2016 Nov 1;44(11):1219-1223. doi: 10.1016/j.ajic.2016.04.231. Epub 2016 Jul 14.PMID: 27424303
- Jindai K (fellow), Sterkel AK, Reed KD, Crnich CJ. Limb Embolism in a 52-Year-Old Woman.Clin Infect Dis. 2016 May 15;62(10):1320-1. doi: 10.1093/cid/ciw081.PMID: 27118830
- Barocas JA (resident), Linas BP, Kim AY, Fangman J, Westergaard RP. Acceptability of Rapid Point-of-Care Hepatitis C Tests Among People Who Inject Drugs and Utilize Syringe-Exchange Programs. Open Forum Infect Dis. 2016 Apr 6;3(2):ofw075. doi: 10.1093/ofid/ofw075. eCollection 2016 Mar.PMID: 27191007
- Safdar N, Odden A, Abad CL, Thapa R (fellow), Saint S. Clinical problem-solving. In sight and out of mind. N Engl J Med. 2015 Jun 4;372(23):2218-23. doi: 10.1056/NEJMcps1413402.PMID: 26039603
- Brennan MB (fellow), Barocas JA (resident), Crnich CJ, Hess TM, Kolehmainen CJ, Sosman JM, Sethi AK. "Oops! I forgot HIV": resident physician self-audits and universal HIV screening. J Infect Public Health. 2015 Mar-Apr;8(2):161-9. doi: 10.1016/j.jiph.2014.08.010. Epub 2014 Sep 29.PMID: 25277258
- Barocas JA (resident), Erlandson KM, Belzer BK, Hess T, Sosman J. Advance directives among people living with HIV: room for improvement. AIDS Care. 2015;27(3):370-7. doi: 10.1080/09540121.2014.963019. Epub 2014 Oct 13.PMID: 25307722
- Jindai K (fellow), Kunzer B, Van TT, Striker R. Human immunodeficiency virus testing pitfalls and clinical suspicion. Am J Emerg Med. 2014 Nov;32(11):1442.e1-2. doi: 10.1016/j.ajem.2014.04.017. Epub 2014 Apr 18.PMID: 24856744
- Nett JE (fellow), Cabezas-Olcoz J, Marchillo K, Mosher DF, Andes DR. Targeting Fibronectin To Disrupt In Vivo Candida albicans Biofilms. Antimicrob Agents Chemother. 2016 Apr 22;60(5):3152-5. doi: 10.1128/AAC.03094-15. Print 2016 May.PMID: 26902759
- Nett JE (fellow), Andes DR. Antifungal Agents: Spectrum of Activity, Pharmacology, and Clinical Indications. Infect Dis Clin North Am. 2016 Mar;30(1):51-83. doi: 10.1016/j.idc.2015.10.012. Epub 2015 Dec 29.PMID: 26739608
- Nett JE (fellow), Andes DR. Fungal Biofilms: In Vivo Models for Discovery of Anti-Biofilm Drugs. Microbiol Spectr. 2015 Jun;3(3):E30. doi: 10.1128/microbiolspec.MB-0008-2014.PMID: 26397003
- Nett JE (fellow), Zarnowski R, Cabezas-Olcoz J, Brooks EG, Bernhardt J, Marchillo K, Mosher DF, Andes DR. Host contributions to construction of three device-associated Candida albicans biofilms. Infect Immun. 2015 Dec;83(12):4630-8. doi: 10.1128/IAI.00931-15. Epub 2015 Sep 14.PMID: 26371129
- Fox EP, Bui CK, Nett JE (fellow), Hartooni N, Mui MC, Andes DR, Nobile CJ, Johnson AD. An expanded regulatory network temporally controls Candida albicans biofilm formation. Version 2. Mol Microbiol. 2015 Jun;96(6):1226-39. doi: 10.1111/mmi.13002. Epub 2015 Apr 23.PMID: 25784162
- Mitchell KF (graduate student), Zarnowski R, Sanchez H, Edward JA, Reinicke EL, Nett JE (fellow), Mitchell AP, Andes DR. Community participation in biofilm matrix assembly and function. Proc Natl Acad Sci U S A. 2015 Mar 31;112(13):4092-7. doi: 10.1073/pnas.1421437112. Epub 2015 Mar 13.
- Nett JE (fellow), Brooks EG, Cabezas-Olcoz J, Sanchez H, Zarnowski R, Marchillo K, Andes DR. Rat indwelling urinary catheter model of Candida albicans biofilm infection. Infect Immun. 2014 Dec;82(12):4931-40. doi: 10.1128/IAI.02284-14. Epub 2014 Sep 2.PMID: 25183731
- Abad CL (fellow), Moseley RH, Crnich CJ, Saint S, Safdar N. Clinical problem-solving. A gut instinct. N Engl J Med. 2014 Aug 7;371(6):560-4. doi: 10.1056/NEJMcps1202137.PMID: 25099581
- Zarnowski R, Westler WM, Lacmbouh GA, Marita JM, Bothe JR, Bernhardt J, Lounes-Hadj Sahraoui A, Fontaine J, Sanchez H, Hatfield RD, Ntambi JM, Nett JE (fellow), Mitchell AP, Andes DR. Novel entries in a fungal biofilm matrix encyclopedia. mBio. 2014 Aug 5;5(4):e01333-14. doi: 10.1128/mBio.01333-14.PMID: 25096878
- Brennan MB (fellow), Kolehmainen C, Barocas J (resident), Isaac C, Crnich CJ, Sosman JM. Barriers and facilitators of universal HIV screening among internal medicine residents. WMJ. 2013 Oct;112(5):199-205.PMID: 24734414
- Taff HT (medical student), Nett JE (fellow), Zarnowski R, Ross KM, Sanchez H, Cain MT, Hamaker J, Mitchell AP, Andes DR. A Candida biofilm-induced pathway for matrix glucan delivery: implications for drug resistance. PLoS Pathog. 2012;8(8):e1002848. doi: 10.1371/journal.ppat.1002848. Epub 2012 Aug 2.PMID: 22876186
- Finkel JS, Xu W, Huang D, Hill EM, Desai JV, Woolford CA, Nett JE (fellow), Taff H (medical student), Norice CT, Andes DR, Lanni F, Mitchell AP. Portrait of Candida albicans adherence regulators. PLoS Pathog. 2012 Feb;8(2):e1002525. doi: 10.1371/journal.ppat.1002525. Epub 2012 Feb 16.PMID: 22359502
- Nett JE (fellow), Marchillo K, Andes DR. Modeling of fungal biofilms using a rat central vein catheter. Methods Mol Biol. 2012;845:547-56. doi: 10.1007/978-1-61779-539-8_40.PMID: 22328403
- Nobile CJ, Fox EP, Nett JE (fellow), Sorrells TR, Mitrovich QM, Hernday AD, Tuch BB, Andes DR, Johnson AD. A recently evolved transcriptional network controls biofilm development in Candida albicans. Cell. 2012 Jan 20;148(1-2):126-38. doi: 10.1016/j.cell.2011.10.048.PMID: 22265407
- Robbins N, Uppuluri P, Nett J (resident), Rajendran R, Ramage G, Lopez-Ribot JL, Andes D, Cowen LE. Hsp90 governs dispersion and drug resistance of fungal biofilms. PLoS Pathog. 2011 Sep;7(9):e1002257. doi: 10.1371/journal.ppat.1002257. Epub 2011 Sep 8.PMID: 21931556
- Nett JE (resident), Sanchez H, Cain MT, Ross KM, Andes DR. Interface of Candida albicans biofilm matrix-associated drug resistance and cell wall integrity regulation. Eukaryot Cell. 2011 Dec;10(12):1660-9. doi: 10.1128/EC.05126-11. Epub 2011 Jun 10.PMID: 21666076
- Taff HT (medical student), Nett JE (resident), Andes DR. Comparative analysis of Candida biofilm quantitation assays. Med Mycol. 2012 Feb;50(2):214-8. doi: 10.3109/13693786.2011.580016. Epub 2011 May 4.PMID: 21539503
- Nett JE (resident), Cain MT (undergraduate), Crawford K, Andes DR. Optimizing a Candida biofilm microtiter plate model for measurement of antifungal susceptibility by tetrazolium salt assay. J Clin Microbiol. 2011 Apr;49(4):1426-33. doi: 10.1128/JCM.02273-10. Epub 2011 Jan 12.PMID: 21227984
- Nett JE (resident), Marchillo K, Spiegel CA, Andes DR. Development and validation of an in vivo Candida albicans biofilm denture model. Infect Immun. 2010 Sep;78(9):3650-9. doi: 10.1128/IAI.00480-10. Epub 2010 Jul 6.PMID: 20605982
- Nett JE (resident), Crawford K, Marchillo K, Andes DR. Role of Fks1p and matrix glucan in Candida albicans biofilm resistance to an echinocandin, pyrimidine, and polyene. Antimicrob Agents Chemother. 2010 Aug;54(8):3505-8. doi: 10.1128/AAC.00227-10. Epub 2010 Jun 1.PMID: 20516280
Getting Funded
Further your research training in a division with over $20M in NIH and foundation funding in FY22.
We make it a priority to help you apply for grants, awards, or other funding opportunities. Your mentor will help you navigate the process.
Our department also offers a pilot award program for residents and fellows, and our Office of Research Services provides biostatistical services, grant writing education and other career development opportunities for learners.